Together, these data indicate that inactivation of SSAO by semicarbazide induces SMCs to switch from a contractile to a synthetic phenotype with increased migratory and proliferative ability, thereby contributing to the accumulation of SMCs and collagens in established lesions under hypercholesterolemia. This evidence concerns the gene AOC3 and familial hypercholesterolemia.